Evidence map›Paper›PMID 34413750›Full record

ArticleCase reports in neurology

Sellar Gangliocytoma: Case Report and Review of an Extremely Rare Tumour.

Pedro José Quiroga-Padilla, Deyanira González-Devia, Rafael Andrade, Paola Escalante, Enrique Jiménez-Hakim

Open access · goldAbstract readCase Reports
In one paragraph

Article in Case reports in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.1field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Pedro José Quiroga-PadillaFaculty of Medicine, Universidad de Los Andes, Bogotá, Colombia.
Deyanira González-DeviaFaculty of Medicine, Universidad de Los Andes, Bogotá, Colombia.
Rafael AndradeFaculty of Medicine, Universidad de Los Andes, Bogotá, Colombia.
Paola EscalanteDepartment of Pathology, Hospital Universitario Fundación Santa Fé de Bogotá, Bogotá, Colombia.
Enrique Jiménez-HakimDepartment of Neurosurgery, Hospital Universitario Fundación Santa Fé de Bogotá, Bogotá, Colombia.
Universidad de Los Andes · COFundación Santa Fe de Bogotá · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sellar gangliocytomas (SGs) are rare, well-differentiated, low-grade neoplasias that commonly present along with a pituitary adenoma (PA). We describe a case of a 52-year-old woman with a 2-year history of headache, body weight increase, and recent onset of arterial hypertension and type 2 diabetes mellitus. Work-up tests revealed a normal hypophyseal profile, except for mild ACTH elevation, and a sellar mass on magnetic resonance imaging (MRI). A diagnosis of an enlarging pituitary macroadenoma was established, and to prevent symptom progression, the tumour was resected. Pathology showed 2 cell populations: ganglion and corticotrope cells. Three years after surgery, the patient no longer had a headache but persisted with arterial hypertension and type 2 diabetes mellitus. A literature review produced 207 cases of SGs. They typically present in women at 40 years of age and the most common clinical presentation are symptoms of acromegaly. Of the documented cases, 74 and 93% were treated with surgery alone or combined treatments (radiotherapy, radiosurgery, or pharmacotherapy), respectively. The majority of deaths associated with a SG came from the first half of the 20th century. In conclusion, this patient presented with a silent SG with likely pituitary hyperplasia. SGs are a challenging diagnosis, have a benign course, and may provide insights into PA tumourigenesis.

Indexed as

Pituitary adenomaPituitary hyperplasiaSellar gangliocytomaTumorigenesis

Identifiers

PMID34413750
PMCPMC8339522
OpenAlexW3195414669

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.